Optimization of sepsis therapy based on patient-specific digital precision diagnostics using next generation sequencing (DigiSep-Trial)—study protocol for a randomized, controlled, interventional, open-label, multicenter trial
Thorsten Brenner(Heidelberg University), Wolfgang Greiner(Bielefeld University), Annabell Skarabis(Essen University Hospital), Peter J. Haug(Intermountain Healthcare), Philip Stevens, Thomas Brückner(Zimmer Biomet (Netherlands)), Thomas M Ruprecht(Techniker Krankenkasse (Germany)), Sibel Altin, Marc Moritz Berger, Mathias W. Pletz(Jena University Hospital), Silke Grumaz, Steffen Luntz(Heidelberg University), Oliver Witzke(Essen University Hospital), Ursula Marschall(BARMER GEK), Jennifer Axnick
Cited by 26
Related Papers
Barriers and Strategies in Guideline Implementation—A Scoping Review
|Healthcare|2016|946
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
|Quality of Life Research|2010|903
German Value Set for the EQ-5D-5L
|PharmacoEconomics|2018|618
The 2018 Lake Louise Acute Mountain Sickness Score
|High Altitude Medicine & Biology|2018|562
Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study
|Quality of Life Research|2010|476